Remimazolam in pediatric surgery under general anesthesia: a case series
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널 순위
- KCI Q2
- 저널
- 고신대학교 의과대학 학술지39(3) · pp.201 · 2024
- 피인용
- KCI 0
- ISSN
- 2005-9531
저자
- 손홍식제1저자Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital
- 박세연Pusan National University Yangsan Hospital
- 윤정필Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital
- 유영민Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital
- 이지민Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital
- 이다은Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital
- 김희영교신저자Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine
초록
Remimazolam is a promising drug for general anesthesia due to its rapid onset, short duration, and short context-sensitive half-life. However, its use in pediatric patients remains off-label, and limited prospective data have been published. Herein, we report successful anesthesia using remimazolam in pediatric patients who had a history of epilepsy or required shared airway surgery. In all cases, remimazolam provided general anesthesia, and flumazenil was used for reversal with rapid recovery. Remimazolam offers advantages for pediatric anesthesia in scenarios with a risk of seizure or shared airway surgery. However, the potential for higher bispectral index values and the risk of anaphylaxis in dextran-allergic patients necessitate caution and further research.
키워드
ChildCase reportsGeneral anesthesiaIntravenous anesthesiaRemimazolam
식별자
- KCI
- ART003122479



로그인
연구물 목록으로